1 정선주, "파킨슨병의 유전 인자" 대한의사협회 54 (54): 70-78, 2011
2 박영례, "파킨슨병 환자의 적극적 삶의 추구과정" 한국간호과학회 36 (36): 710-720, 2006
3 김성렬, "파킨슨병 환자의 삶의 질에 영향을 미치는 요인" 대한신경과학회 23 (23): 770-775, 2005
4 이기옥, "젊은 나이에 산발성 파킨슨병이 생긴 한국인 환자의 Parkin 유전자 변이" 대한신경과학회 24 (24): 26-30, 2006
5 Williams, S., "‘stony road… 19 year journey’ ‘ridging’ hrough late-stage Parkinson’ disease" 13 (13): 373-388, 2008
6 Schrag, A, "Young-versus older-onset Parkinson’s disease: Impact of disease and psychosocial consequences" 18 (18): 1250-1256, 2003
7 Calne, S. M, "Young onset Parkinson’s disease. Practical management of medical issues" 14 (14): 133-142, 2008
8 Kostić, V. S, "Treatment of young-onset Parkinson’s disease: Role of dopamine receptor agonists" 15 (15): S71-S75, 2009
9 Stocchi, F, "Treatment of levodopa-induced motor complications" 23 (23): S599-S612, 2008
10 Chick, N., "Transitions: A nursing concern, In Nursing research methodology: Issues and implementation" Aspen Publishers 237-257, 1986
1 정선주, "파킨슨병의 유전 인자" 대한의사협회 54 (54): 70-78, 2011
2 박영례, "파킨슨병 환자의 적극적 삶의 추구과정" 한국간호과학회 36 (36): 710-720, 2006
3 김성렬, "파킨슨병 환자의 삶의 질에 영향을 미치는 요인" 대한신경과학회 23 (23): 770-775, 2005
4 이기옥, "젊은 나이에 산발성 파킨슨병이 생긴 한국인 환자의 Parkin 유전자 변이" 대한신경과학회 24 (24): 26-30, 2006
5 Williams, S., "‘stony road… 19 year journey’ ‘ridging’ hrough late-stage Parkinson’ disease" 13 (13): 373-388, 2008
6 Schrag, A, "Young-versus older-onset Parkinson’s disease: Impact of disease and psychosocial consequences" 18 (18): 1250-1256, 2003
7 Calne, S. M, "Young onset Parkinson’s disease. Practical management of medical issues" 14 (14): 133-142, 2008
8 Kostić, V. S, "Treatment of young-onset Parkinson’s disease: Role of dopamine receptor agonists" 15 (15): S71-S75, 2009
9 Stocchi, F, "Treatment of levodopa-induced motor complications" 23 (23): S599-S612, 2008
10 Chick, N., "Transitions: A nursing concern, In Nursing research methodology: Issues and implementation" Aspen Publishers 237-257, 1986
11 Kralik, D., "Transition: A literature review" 55 (55): 320-329, 2006
12 Fox, S. H, "The movement disorder society evidence-based medicine review update: Treatments for the motor symptoms of Parkinson’s disease" 26 (26): S2-S41, 2011
13 Calne, S. M, "Psychosocial issues in young-onset Parkinson’s disease: Current research and challenges" 14 (14): 143-150, 2008
14 Ellis, J. M., "Psychological transition into a residential care facility: Older people's experiences" 66 (66): 1159-1168, 2010
15 Periquet, M., "Parkin mutations are frequent in patients with isolated early-onset parkinsonism" 126 (126): 1271-1278, 2003
16 Burgener, S. C, "Measuring perceived stigma in persons with progressive neurological disease: Alzheimer's dementia and Parkinson’s disease" 7 (7): 31-53, 2008
17 Whitney, C. M., "Maintaining the square. How older adults with Parkinson’s disease sustain quality in their lives" 30 (30): 28-35, 2004
18 Haahr, A., "Living with advanced Parkinson’s disease: A constant struggle with unpredictability" 67 (67): 408-417, 2011
19 Fox, S. H, "Levodopa-related motor complicationsphenomenology" 23 (23): S509-S514, 2008
20 Meleis, A. I., "Experiencing transitions : An emerging middle-range theory" 23 (23): 12-28, 2000
21 de Lau, L. M, "Epidemiology of Parkinson’s disease" 5 (5): 525-535, 2006
22 Schrag, A, "Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism" 5 (5): 355-363, 2006
23 Guba, E. G., "Effective evaluation: Improving the usefulness of evaluation results through responsive and naturalistic approaches" Jossey-Bass 1981
24 Schrag, A., "Cross sectional prevalence survey of idiopathic Parkinson’s disease and Parkinsonism in London" 321 (321): 21-22, 2000
25 Strauss, A., "Basics of qualitative research: Techniques and procedures for developing grounded theory" Sage Publications, Inc 1998
26 National Health Insurance Service, "2002-2008 medical treatment trends analysis of geriatric diseases in Korea"